HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RB Targets UK’s Hedonistic ‘Generation Z’ With Ironic Gaviscon Campaign

Executive Summary

Reckitt Benckiser extends its "Night Labs" Gaviscon campaign aimed at UK 20-something heartburn sufferers with two new tongue in cheek videos.

Party-going, late-night drinking, kebab-eating 20-somethings are the focus of Reckitt Benckiser Group PLC’s latest campaign for its blockbuster heartburn remedy Gaviscon in the UK.

Under the “Night Labs” banner, scientists in a pair of ironic videos concoct “hilariously over-the-top solutions” to common heartburn triggers such as fatty foods and eating too fast, RB explained.

 

 

One of two new videos for Gaviscon created by Havas London
Open Media

Behind the tongue-in-cheek presentation, however, the key message of the videos – created by Havas London – was that a “much simpler and far more serious solution actually exists” for heartburn, RB pointed out: Gaviscon Double Action tablets.

Alongside the videos, which would be promoted online and via paid social media advertising, RB said it had also created a “campaign microsite” which would “host recipes, useful information and a competition in which participants can with their very own Night Labs Test Kit.”

Inspired by the videos, RB said that the Night Labs Test Kit included “takeaway vouchers, anti-heartburn innovations such a crazy wiggly straw and tiny knife and fork to slow down the pace of eating and, just in case these  don’t work, vouchers for Gaviscon Double Action tablets.”

Explaining the strategy behind the campaign, RB said it was an extension of its existing “Go On” brand platform, which looked to establish Gaviscon as the go-to heartburn remedy among members of Generation Z, as they began to feel the effects of their hedonistic lifestyles as they moved through their 20s.

Young people first started feeling the effects of their “fast-paced lives of work and socializing” at roughly 23-years old, RB explained. “Despite this, people in their twenties rarely acknowledge the problem, let alone embrace a serious solution,” the firm continued. “Instead, they try their best to keep going, determined that heartburn won’t ruin their fun.”

RB was therefore positioning the brand as a “facilitator of good times, helping this experience-loving audience to literally ‘go on’ – without their fun being tarnished by heartburn and indigestion.”

“It’s not just that this demographic tends to ignore symptoms of heartburn and indigestion and rarely embraces a serious solution,” added RB’s marketing director, Charlotte Schloesing. “But also the fact that 75% of consumers remain loyal to their first form of treatment.”

“We’re determined to show this younger audience that Gaviscon has them covered when heartburn and indigestion strike," Schloesing said, "enabling them to go on with their fun times.”

 

 

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149223

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel